Alcohol Addiction – Global Clinical Trials Review, 2022

Pages: 461 Published: February 23, 2022 Report Code: GDHC6847CTIDB

The alcohol addiction clinical trial report provides a comprehensive overview of trials count and their average enrollment in top countries conducted globally. The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on number of ongoing trials).

What are the market dynamics in the alcohol addiction clinical trials market?

Alcohol addiction clinical trial report consists of more than 800 trials. Trials conducted by companies are in Phase IV, Phase III, Phase II, Phase I and Phase 0. Similarly, the trials with different status compile of completed, ongoing, planned, suspended, terminated and withdrawn.

Which are the key regions in the alcohol addiction clinical trials market?

The key regions in the alcohol addiction clinical trials market are Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America.

Alcohol addiction clinical trials market in Asia-Pacific

The top five countries in Asia-Pacific in the alcohol addiction clinical trials market are China, South Korea, India, Australia, and Japan. Australia has the highest number of clinical trials, followed by India, China, Japan, and South Korea.

Alcohol addiction clinical trials market in Europe

The top five countries in Europe in the alcohol addiction clinical trials market are Russia, Germany, the United Kingdom, Spain, and France. Germany has the highest number of clinical trials, followed by France, Russia, the UK, and Spain.

Alcohol addiction clinical trials market in North America

The top two countries in North America in the alcohol addiction clinical trials market are the US and Canada. The US has the highest number of clinical trials followed by Canada.

Alcohol addiction clinical trials market in the Middle East & Africa

The top five countries in the Middle East & Africa in the alcohol addiction clinical trials market are Iran, Israel, Lebanon, South Africa, and Uganda. Iran has the highest number of clinical trials, followed by Israel, Lebanon, South Africa, and Uganda.

Alcohol addiction clinical trials market in South & Central America

The top two countries in South & Central America in the alcohol addiction clinical trials market are Brazil and Peru. Brazil has the highest number of clinical trials followed by Peru.

Alcohol addiction clinical trials market in G7 countries

The G7 countries in the alcohol addiction clinical trials market include the US, the UK, Germany, France, Italy, Canada and Japan. The US have the highest number of alcohol addiction clinical trials as of February 2022

Alcohol addiction clinical trials market in E7 countries

The E7 countries in the alcohol addiction clinical trials market include Brazil, Russia, India, China, Mexico, Turkey and Indonesia. Russia has the highest number of alcohol addiction clinical trials as of February 2022.

Alcohol addiction clinical trial market, by key region

Alcohol addiction clinical trial market, by key region

For more regional insights, download a free sample

Which are the key sponsors in the alcohol addiction clinical trials market?

The key sponsors in the alcohol addiction clinical trials market are Alkermes Plc, The Lundbeck Foundation, Pfizer Inc, Johnson & Johnson, Eli Lilly and Co, Otsuka Holdings Co Ltd, Merck & Co Inc, Indivior Plc, GlaxoSmithKline Plc, and AstraZeneca Plc.

Alcohol addiction clinical trial market, by key sponsors

Alcohol addiction clinical trial market, by key sponsors

To know more about key sponsors, download a free sample

Market report scope

Key regions Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America
Key phases Phase IV, Phase III/IV, Phase III, Phase II/III, Phase II, Phase I/II, Phase I, and Phase 0
Key sponsors Alkermes Plc, The Lundbeck Foundation, Pfizer Inc, Johnson & Johnson, Eli Lilly and Co, Otsuka Holdings Co Ltd, Merck & Co Inc, Indivior Plc, GlaxoSmithKline Plc, and AstraZeneca Plc.

Scope

  • The report provides a snapshot of the global clinical trials landscape.
  • Report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end point status.
  • The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company.
  • The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with the reason for failure.
  • The report provides enrollment trends for the past five years.
  • Report provides the latest news for the past three months.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of global clinical trials market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Key Players

Alkermes Plc
The Lundbeck Foundation
Pfizer Inc
Eli Lilly and Co
Johnson & Johnson
AstraZeneca Plc
GlaxoSmithKline Plc
Indivior Plc
Merck & Co Inc
Otsuka Holdings Co Ltd

Table of Contents

Table of Contents

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Clinical Trials by G7 Countries: Proportion of Alcohol Addiction to Central Nervous System Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Alcohol Addiction to Central Nervous System Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Alcohol Addiction Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About GlobalData

Contact Us

Source

List of Tables

List of Tables

Alcohol Addiction Therapeutics, Global, Clinical Trials by Region, 2022*

Alcohol Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*

Alcohol Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2022*

Alcohol Addiction Therapeutics Clinical Trials, North America, Top Countries, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2022*

Proportion of Alcohol Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2022*

Alcohol Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*

Alcohol Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*

Proportion of Alcohol Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2022*

Alcohol Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*

Alcohol Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*

Alcohol Addiction Therapeutics, Global, Clinical Trials by Phase, 2022*

Alcohol Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2022*

Alcohol Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021

Alcohol Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

List of Figures

List of Figures

Alcohol Addiction Therapeutics, Global, Clinical Trials by Region (%), 2022*

Alcohol Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*

Alcohol Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2022*

Alcohol Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2022*

Alcohol Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2022*

Alcohol Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2022*

Alcohol Addiction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2022*

Proportion of Alcohol Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2022*

Alcohol Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*

Alcohol Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*

Proportion of Alcohol Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2022*

Alcohol Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*

Alcohol Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*

Alcohol Addiction Therapeutics, Global, Clinical Trials by Phase (%), 2022*

Alcohol Addiction Therapeutics, Global, Clinical Trials In Progress by Phase, 2022*

Alcohol Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021

Alcohol Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2022*

Alcohol Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*

Alcohol Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

GlobalData Methodology

Frequently Asked Questions

Asia-Pacific, Europe, North America, Middle East & Africa, and South & Central America are the key regions in the alcohol addiction clinical trials market.

The key phases in the alcohol addiction clinical trials market are Phase IV, Phase III/IV, Phase III, Phase II/III, Phase II, Phase I/II, Phase I, and Phase 0.

Alkermes Plc, The Lundbeck Foundation, Pfizer Inc, Johnson & Johnson, Eli Lilly and Co, Otsuka Holdings Co Ltd, Merck & Co Inc, Indivior Plc, GlaxoSmithKline Plc, and AstraZeneca Plc. are the key sponsors in the alcohol addiction clinical trials market.

$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods